ESR1 and breast cancer: For example, the presence of cytotoxic T-cells (CD8+) has been associated with better survival in estrogen receptor (ER)-negative and ER-positive/human epidermal growth factor receptor 2 (Her2)-positive breast cancer subtypes [14].